| HOME >> MEDICINE >> TECHNOLOGY |
5956Additional paid-in capital
551,594489,542Accumulated deficit
(344,981)(329,828)Accumulated other comprehensive income (loss)
470(68)Treasury stock, at cost: 541,584 and 480,923 shares as of December 31, 2012 and 2011, respectively
(9,551)(8,516)Total stockholders' equity
197,591151,186Total liabilities and stockholders' equity
$
311,949$
291,708
NxStage Medical, Inc.
Cash Flows from Operating Activities
(in thousands)
(unaudited) Twelve Months Ended
December 31,20122011Cash flows from operating activities:Net loss
$
(15,153)$
(21,402)Adjustments to reconcile net loss to net cash provided by (used in) operating activities:Depreciation and amortization
23,67323,087Stock-based compensation
11,40313,093Other
3,5173,064Changes in operating assets and liabilities:Accounts receivable
(3,141)(1,773)Inventory
(14,545)(16,371)Prepaid expenses and other assets
(1,623)(1,491)Accounts payable
839(1,047)Accrued expenses and other liabilities
5,263(324)Deferred revenues
(3,992)1,648Net cash provided by (used in) operating activities
$
6,241$
(1,516)
NxStage Medical, Inc.Revenues by Segment(in thousands)(unaudited)Three Months Ended
December 31,Twelve Months Ended
December 31,2012201120122011System One segmentHome
$
31,418$
28,213$
123,589$
108,489Critical Care
11,2839,79239,54034,991Total System One segment
42,70138,005163,129143,480In-Center segment
21,45019,01676,92773,776Other
869—2,076—Total
$
65,020$
57,021$
242,132$
217,256
NxStage Medical, Inc.Non-GAAP Financial Measures(in millions)(unaudited)Three Months Ended
December 31,Twelve Months Ended <
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2012 PR Newswire. All rights reserved |